Filed: 5/8/2026ACC: 0001140361-26-019665
📋 What this filing means
AJU IB INVESTMENT CO., LTD. filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $30.52M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$30.52M
Total AUM (reported)
1.22M
Total Shares
Allocation by class
COMMON STOCK$25.66M84.1%
COM$2.88M9.4%
COM CL A$1.54M5.1%
COM SHS$435.9K1.4%
Portfolio Concentration
Top 3$28.84M94.5%
4–10$1.68M5.5%
Top 3 weight
94.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 1.22M
Sole
Full voting authority
1.22M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
ARCELLX INC
SOLEShares223.49K
TypeSH
Market value$25.66M
84.07%
Sole
223.49K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares19.65K
TypeSH
Market value$1.64M
5.36%
Sole
19.65K
Shared
0.00
None
0.00
SEER INC
SOLEShares816.38K
TypeSH
Market value$1.54M
5.05%
Sole
816.38K
Shared
0.00
None
0.00
RALLYBIO CORP
SOLEShares94.33K
TypeSH
Market value$846.2K
2.77%
Sole
94.33K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares17.50K
TypeSH
Market value$435.9K
1.43%
Sole
17.50K
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares47.70K
TypeSH
Market value$401.1K
1.31%
Sole
47.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARCELLX INCSOLE | COMMON STOCK | 223.49K | SH | $25.66M 84.07% | 223.49K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 19.65K | SH | $1.64M 5.36% | 19.65K | 0.00 | 0.00 |
SEER INCSOLE | COM CL A | 816.38K | SH | $1.54M 5.05% | 816.38K | 0.00 | 0.00 |
RALLYBIO CORPSOLE | COM | 94.33K | SH | $846.2K 2.77% | 94.33K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM SHS | 17.50K | SH | $435.9K 1.43% | 17.50K | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 47.70K | SH | $401.1K 1.31% | 47.70K | 0.00 | 0.00 |